Pivotal pharmacokinetic bridging clinical study anticipated to begin in May. Malvern, PA – SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products for the treatment of pain, today announced that it...

Read more

Funds to be used for the clinical development of the Company’s first product Ztlido™ (lidocaine patch 1.8%) Malvern, PA – SCILEX Pharmaceuticals, Inc., today announced that the company has entered into definitive agreements for a...

Read more